Jyothy Labs Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Jyothy Labs Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Jyothy Labs Ltd.
Rating: 5
Author: ICICI Securities Limited

Keep track of all breaking news and updates on Jyothy Labs Ltd. from all sources in a single place.

Jyothy Labs Ltd.

17 Nov 2025

309.80

-0.11%

SAST

Jyothy Labs Ltd - 532926 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for M P Ramachandran Family Trust I & PACs

pdf

Jyothy Labs Ltd.

15 Nov 2025

309.80

-0.11%

Earnings Call

Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the earnings Call held on Wednesday, November 12, 2025 for analyst / investors to discuss the Un-audited financial results for the quarter and half year ended September 30, 2025 and the way forward

pdf

Jyothy Labs Ltd.

15 Nov 2025

309.80

-0.11%

Company Update

Jyothy Labs Ltd - 532926 - Disclosure Under Regulation 30 Read With Schedule III Of The …

BSE India

Disclosure under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Jyothy Labs Ltd.

15 Nov 2025

309.80

-0.11%

Company Update

Jyothy Labs Ltd - 532926 - General-Updates

BSE India

Addition in members of the promoter Group of the Company

pdf

Jyothy Labs Ltd.

14 Nov 2025

309.80

-0.11%

Company Update

Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Announcement under Regulation 30 (LODR) - Analyst / Investor Meet

pdf

Jyothy Labs Ltd.

13 Nov 2025

309.80

-0.11%

Company Update

Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication

pdf

Jyothy Labs Ltd.

13 Nov 2025

309.80

-0.11%

Jyothy Labs Q2 Review Weak Quarter Despite Volume Growth, Says Motilal Oswal Maintaining 'Neutral' Stance

NDTV Profit

Market share gains, the success of new launches, a recovery in personal care, and the turnaround of HI portfolio will be crucial for Jyothy Labs' earnings growth.

Number of FII/FPI investors decreased from 197 to 188 in Sep 2025 qtr

Jyothy Labs Ltd.

13 Nov 2025

309.80

-0.11%

Short-term disruption; recovery on track

Buy: Jyothy Labs Ltd.

Target

ICICI Securities Limited

JYL’s Q2FY26 performance was impacted by GST-led disruption and pricing/grammage adjustments (value/volume growth of 0.4%/2.8% YoY).

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

13 Nov 2025

309.80

-0.11%

Result Update:Jyothy Labs

Hold: Jyothy Labs Ltd.

Target

Axis Direct

Considering the near-term challenges, we maintain our HOLD rating on the stock and revise our TP to Rs 320/share. The TP implies an upside potential of 3% from the CMP.